4//SEC Filing
O'Meara Maeve 4
Accession 0001209191-21-065650
CIK 0001433714other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 7:56 PM ET
Size
29.4 KB
Accession
0001209191-21-065650
Insider Transaction Report
Form 4
O'Meara Maeve
EVP,Product&CustomerExperience
Transactions
- Sale
Class B Common Stock
2021-11-17$1.77/sh−99,009$175,513→ 1,625,989 total - Exercise/Conversion
Class B Common Stock
2021-11-16+62,000→ 1,691,873 total - Exercise/Conversion
Restricted Stock Units (RSU)
2021-11-16−62,000→ 558,000 total→ Class B Common Stock (62,000 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2021-11-16−33,125→ 430,625 total→ Class B Common Stock (33,125 underlying) - Exercise/Conversion
Class B Common Stock
2021-11-16+12,500→ 1,551,208 total - Exercise/Conversion
Restricted Stock Units (RSU)
2021-11-16−12,500→ 25,000 total→ Class B Common Stock (12,500 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2021-11-16−23,062→ 115,313 total→ Class B Common Stock (23,062 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2021-11-16−43,103→ 301,725 total→ Class B Common Stock (43,103 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2021-11-16−12,500→ 12,500 total→ Class B Common Stock (12,500 underlying) - Exercise/Conversion
Class B Common Stock
2021-11-16+12,500→ 1,563,708 total - Exercise/Conversion
Class B Common Stock
2021-11-16+23,062→ 1,586,770 total - Exercise/Conversion
Class B Common Stock
2021-11-16+43,103→ 1,629,873 total - Exercise/Conversion
Class B Common Stock
2021-11-16+33,125→ 1,724,998 total
Footnotes (9)
- [F1]Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $1.755 to $1.83 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F3]Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
- [F4]1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
- [F5]1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
- [F6]1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
- [F7]1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
- [F8]1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
- [F9]1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
Documents
Issuer
CASTLIGHT HEALTH, INC.
CIK 0001433714
Entity typeother
Related Parties
1- filerCIK 0001742487
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 7:56 PM ET
- Size
- 29.4 KB